Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Colorectal Neoplasms

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 92 articles: HTML format

Single Articles

September 2025
1. WADA N, Nishida N, Takeda M, Sekido Y, et al
   Efficacy and Safety of S-1 and Oxaliplatin With Radiotherapy for Anorectal Cancer.
   Anticancer Res. 2025;45:3847-3857.
   PubMed     Abstract available
   
   
   
2. OTANI K, Kazama K, Aoyama T, Hashimoto I, et al
   Geriatric Nutritional Risk Index Predicts Prognosis in Older Patients With Colorectal Cancer: A Multicenter Study.
   Anticancer Res. 2025;45:4015-4025.
   PubMed     Abstract available
   
   
   
3. KOKAINE L, Daneberga Z, Satcs M, Zvina D, et al
   The Prognostic Role of microRNAs 142-5p, 182-3p, and 99a-3p in Locally Advanced Rectal Cancer Patients.
   Anticancer Res. 2025;45:3895-3912.
   PubMed     Abstract available
   
   
   
4. KIM J, Han Q, Li S, Kang BM, et al
   Combinations of Salmonella typhimurium A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal Fibroblasts.
   Anticancer Res. 2025;45:3661-3668.
   PubMed     Abstract available
   
   
   
5. NOZAWA H, Kasuga SO, Murono K, Sasaki K, et al
   Effects of Neoadjuvant Treatments on Mesorectal Computed Tomography Values and Tumor Regression in Rectal Cancer.
   Anticancer Res. 2025;45:3921-3930.
   PubMed     Abstract available
   
   
   
6. KIMURA N, Hiraki M, Furukawa S, Ikuno H, et al
   Oncological Outcomes of Varying Resection Margin Lengths in Colon Cancer Surgery: A Retrospective Analysis.
   Anticancer Res. 2025;45:4005-4013.
   PubMed     Abstract available
   
   
   August 2025
7. OGURA A, Murata Y, Sando M, Kobayashi R, et al
   Response-guided Strategy Based on Induction Chemotherapy Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer.
   Anticancer Res. 2025;45:3393-3398.
   PubMed     Abstract available
   
   
   
8. MUKOHYAMA J, Saito I, Mochizuki S, Ota Y, et al
   Endometrial Cancer Metastatic to the Sigmoid Colon and Pelvic Retroperitoneal Space: A Case Report.
   Anticancer Res. 2025;45:3567-3573.
   PubMed     Abstract available
   
   
   
9. LEE S, Koh JW, Lee JH, Park SJ, et al
   Silencing of Acyl-CoA Thioesterase 7 Inhibits Proliferation and Metastatic Potential in Colorectal Cancer Cells.
   Anticancer Res. 2025;45:3315-3325.
   PubMed     Abstract available
   
   
   July 2025
10. HUANG CW, Yang JS, Tsai YF, Kuo SC, et al
    Anti-cancer Effects of a Novel Curcumin Derivative, 4,4-Diallyl Curcumin Bis(2,2-Hydroxymethyl)Propanoate (35e), on Radio-resistant Colorectal Cancer Cells.
    Anticancer Res. 2025;45:2891-2904.
    PubMed     Abstract available
    
    
    
11. ASANO Y, Han Q, Li S, Mizuta K, et al
    The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human Fibroblasts.
    Anticancer Res. 2025;45:2825-2831.
    PubMed     Abstract available
    
    
    
12. KIM J, Han Q, Kang BM, Mizuta K, et al
    The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells.
    Anticancer Res. 2025;45:2773-2779.
    PubMed     Abstract available
    
    
    
13. LEE J, Kim H, Moon J, Nualsanit T, et al
    Damnacanthal Suppresses TCF4 Expression in Colorectal Cancer Cells.
    Anticancer Res. 2025;45:2847-2858.
    PubMed     Abstract available
    
    
    
14. KANG BM, Han Q, Li S, Mizuta K, et al
    The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No Return.
    Anticancer Res. 2025;45:2817-2823.
    PubMed     Abstract available
    
    
    
15. NGUYEN MLT, Bui LA, Pham C, Nham PLT, et al
    Adiponectin Receptor Agonist Suppresses Human Colorectal Cancer.
    Anticancer Res. 2025;45:3059-3068.
    PubMed     Abstract available
    
    
    
16. VAN BUSSEL MTJ, Bravenboer N, Essen HV, Snaebjornsson P, et al
    Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial.
    Anticancer Res. 2025;45:3137-3147.
    PubMed     Abstract available
    
    
    
17. SUETSUGU F, Tadokoro T, Fujita K, Fujihara S, et al
    Antitumor Effects of Epigallocatechin-3-Gallate on Colorectal Cancer: An In Vitro and In Vivo Study.
    Anticancer Res. 2025;45:2937-2947.
    PubMed     Abstract available
    
    
    June 2025
18. MINAMI S, Miyoshi N, Fujino S, Yasui M, et al
    Role of the Circadian Clock Gene DEC1 in Chemosensitivity and Apoptosis in Colorectal Cancer.
    Anticancer Res. 2025;45:2309-2328.
    PubMed     Abstract available
    
    
    
19. YU X, Tsunedomi R, Hazama S, Nakagami Y, et al
    Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis.
    Anticancer Res. 2025;45:2385-2399.
    PubMed     Abstract available
    
    
    
20. ANDO Y, Orito H, Mizuno T, Katsuno H, et al
    Effect of a Biweekly Dosing Schedule on Severe Neutropenia Induced by Trifluridine/Tipiracil in Colorectal Cancer.
    Anticancer Res. 2025;45:2587-2594.
    PubMed     Abstract available
    
    
    
21. ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al
    Four Different Artificial Intelligence Models Versus Logistic Regression to Enhance the Diagnostic Accuracy of Fecal Immunochemical Test in the Detection of Colorectal Carcinoma in a Screening Setting.
    Anticancer Res. 2025;45:2477-2491.
    PubMed     Abstract available
    
    
    
22. KODAMA H, Yamaguchi T, Kameishi S, Kadono T, et al
    Tumor Budding Grade and T Stage as Recurrence Predictors of High-risk Stage II Colorectal Cancer.
    Anticancer Res. 2025;45:2619-2628.
    PubMed     Abstract available
    
    
    
23. KATAOKA A, Kawasaki T, Kaira K, Hirano Y, et al
    Pathological Investigation of Grasping-related Mesenteric Injury During Laparoscopic Colorectal Cancer Resection.
    Anticancer Res. 2025;45:2493-2499.
    PubMed     Abstract available
    
    
    
24. ASANO Y, Han Q, Li S, Mizuta K, et al
    Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts.
    Anticancer Res. 2025;45:2257-2263.
    PubMed     Abstract available
    
    
    
25. KOBAYASHI Y, Takano Y, Matsukida S, Takishima T, et al
    Prognostic Nutritional Index Is the Key Prognostic Factor in Elderly Patients With Colorectal Cancer.
    Anticancer Res. 2025;45:2595-2603.
    PubMed     Abstract available
    
    
    May 2025
26. HWANG HH, Yoo JS, Je JH, Lee HC, et al
    SH003 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Through the RTK-STAT3 Pathway.
    Anticancer Res. 2025;45:1965-1980.
    PubMed     Abstract available
    
    
    
27. IZUTANI Y, Ogino T, Fujii M, Sekido Y, et al
    Appendectomy Mitigates Ulcerative Colitis Activity and Delays Colorectal Cancer Onset: A Retrospective Cohort Study.
    Anticancer Res. 2025;45:2205-2214.
    PubMed     Abstract available
    
    
    April 2025
28. OKEMOTO D, Yamaguchi T, Sugino K, Matsuo N, et al
    Chemotherapy Efficacy in Patients With Colorectal Cancer Experiencing Early Recurrence During or After Adjuvant Chemotherapy.
    Anticancer Res. 2025;45:1695-1705.
    PubMed     Abstract available
    
    
    
29. YUEH TC, Chen YJ, Mong MC, Ke TW, et al
    The Contribution of Interleukin-12A and Interleukin-12B Genotypes to Colorectal Cancer in Taiwan.
    Anticancer Res. 2025;45:1501-1512.
    PubMed     Abstract available
    
    
    
30. NII T, Yoshimi T, Tanito K, Hijii S, et al
    Inflammation-triggering Engineered Macrophages (MacTriggers) Are Promising Cell-based Therapeutic Avenues for Chemoresistant Solid Tumors.
    Anticancer Res. 2025;45:1395-1405.
    PubMed     Abstract available
    
    
    
31. SUGIMOTO K, Irie T, Momose H, Kochi S, et al
    Circulating Tumor DNA Methylation Is a Biomarker of Poor Recurrence-free Survival in Locally-Advanced Rectal Cancer.
    Anticancer Res. 2025;45:1559-1573.
    PubMed     Abstract available
    
    
    March 2025
32. TERAISHI F, Yoshida Y, Shoji R, Kanaya N, et al
    Short-term Safety of Robot-assisted Rectal Surgery in Patients Aged >/=75 Years: A Single-center Retrospective Study.
    Anticancer Res. 2025;45:1291-1299.
    PubMed     Abstract available
    
    
    
33. WEISS TS, Buechler C
    Proprotein Convertase Subtilisin/Kexin Type 9 Induction in Hypercholesterinemic Patients With Primary and Metastatic Liver Tumors.
    Anticancer Res. 2025;45:1171-1180.
    PubMed     Abstract available
    
    
    
34. SHOJI R, Teraishi F, Kondo Y, Yoshida Y, et al
    Tailoring Neoadjuvant Therapy for Rectal Cancer: A Single-center Study of Local Recurrence Patterns.
    Anticancer Res. 2025;45:1261-1271.
    PubMed     Abstract available
    
    
    
35. GOTO K, Ryu S, Imaizumi Y, Iwauchi S, et al
    Urethral Visualization Using Near-infrared Light Observation During Transanal/Perineal Total Mesorectal Excision.
    Anticancer Res. 2025;45:1241-1249.
    PubMed     Abstract available
    
    
    
36. SUGIYAMA M, Kasagi Y, Yokomizo R, Terashi M, et al
    Oncologic Relevance and Anal Preservation Potential of Transanal Total Mesorectal Excision for Rectal Cancer Invading Adjacent Organs.
    Anticancer Res. 2025;45:1233-1239.
    PubMed     Abstract available
    
    
    February 2025
37. DREVS J, Malhotra MS, Sahinbas H, Iliopoulos A, et al
    Adjusting Treatment Strategies Using Circulating Tumor Cells: Preliminary Results on Metastatic Colorectal Cancer.
    Anticancer Res. 2025;45:491-502.
    PubMed     Abstract available
    
    
    
38. YANG IJ, Kim DH, Lee KH, Kim JY, et al
    Safety and Survival Benefit of Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colon Cancer.
    Anticancer Res. 2025;45:797-809.
    PubMed     Abstract available
    
    
    
39. TAKISHIMA T, Kobayashi Y, Matsukida S, Kai W, et al
    Negative Impact of Low Serum Cholinesterase on Short- and Long-term Outcomes in Elderly Patients Undergoing Scheduled Surgery for Colorectal Cancer.
    Anticancer Res. 2025;45:743-750.
    PubMed     Abstract available
    
    
    January 2025
40. KAWAMURA H, Imaizumi T, Miyakawa T, Nakao E, et al
    Development of a Prognostic Model for Stage IV Colorectal Cancer Using Metastatic Patterns.
    Anticancer Res. 2025;45:341-350.
    PubMed     Abstract available
    
    
    
41. ZHANG Y, Li X, Li S, Yang Z, et al
    Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therap
    Anticancer Res. 2025;45:399-404.
    PubMed     Abstract available
    
    
    
42. KASUGA SO, Nozawa H, Ishihara S
    Changes in Mesorectal CT Values and Therapeutic Effect of Preoperative Chemoradiotherapy in Rectal Cancer.
    Anticancer Res. 2025;45:359-367.
    PubMed     Abstract available
    
    
    
43. ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al
    Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting.
    Anticancer Res. 2025;45:267-275.
    PubMed     Abstract available
    
    
    
44. TSAI YY, Ke TW, Huang CH, Chen TW, et al
    Prognostic Relevance of Immunosuppressive CD155/TIGIT Signaling in Locally Advanced Rectal Cancer Patients With Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2025;45:323-333.
    PubMed     Abstract available
    
    
    December 2024
45. KIM HB, Choi WY, Kim SH, Lee HJ, et al
    GNAO1: A Novel Tumor Suppressor Gene in Colorectal Cancer Pathogenesis.
    Anticancer Res. 2024;44:5425-5433.
    PubMed     Abstract available
    
    
    
46. SHIBUTANI M, Kashiwagi S, Tanda H, Seki Y, et al
    Prognostic Significance of Innovative Inflammation-nutrition Biomarker Score in Patients With Colorectal Cancer.
    Anticancer Res. 2024;44:5559-5567.
    PubMed     Abstract available
    
    
    
47. SHIN H, Kim Y, Lee Y, Kim J, et al
    Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer.
    Anticancer Res. 2024;44:5435-5443.
    PubMed     Abstract available
    
    
    
48. LEE Y, Kim Y, Shin H, Ryu YC, et al
    Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors.
    Anticancer Res. 2024;44:5313-5322.
    PubMed     Abstract available
    
    
    November 2024
49. ZADOROZNYJ A, Karam E, Michot N, Thiery J, et al
    Clinical and Oncological Impact of a Protective Ileostomy in Rectal Cancer Patients Undergoing Adjuvant Chemotherapy.
    Anticancer Res. 2024;44:4995-5005.
    PubMed     Abstract available
    
    
    
50. NGUYEN MLT, Pham C, Nguyen TS, Nham PLT, et al
    Single-agent Adavosertib Shows Anticancer Effects Against Colorectal Cancer Cells.
    Anticancer Res. 2024;44:4941-4949.
    PubMed     Abstract available
    
    
    
51. YASUI C, Kono Y, Ishiguro R, Yagyu T, et al
    New Treatment Modalities for Colorectal Cancer Through Simultaneous Suppression of FSP1 and GPX4.
    Anticancer Res. 2024;44:4905-4914.
    PubMed     Abstract available
    
    
    
52. SUNG YN, Kim Y, Datuin AT, Jang I, et al
    Routine Elastic Staining Helps Detection of Vascular Invasion in Colorectal Cancer: A Comprehensive Analysis of T3 or Higher Tumors Without Lymph Node Metastasis.
    Anticancer Res. 2024;44:5059-5065.
    PubMed     Abstract available
    
    
    October 2024
53. UNRUG-BIELAWSKA K, Earnshaw D, Cybulska-Lubak M, Kaniuga E, et al
    Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3D In Vitro Cultures.
    Anticancer Res. 2024;44:4219-4224.
    PubMed     Abstract available
    
    
    
54. RUBIO CA, Vieth M, Lang-Schwarz C
    Nondysplastic Colon Crypts Intercalated in Tubular Adenomas Support Field Cancerization.
    Anticancer Res. 2024;44:4371-4377.
    PubMed     Abstract available
    
    
    
55. HOSIK J, Hosikova B, Kolarova H, Bajgar R, et al
    5,10,15,20-Tetrakis(4-sulfonatophenyl)porphyrin Zinc and Chloro-aluminum Phthalocyanine Disulfonate in Photodynamic Therapy of Colorectal Adenocarcinoma In Vitro.
    Anticancer Res. 2024;44:4339-4346.
    PubMed     Abstract available
    
    
    
56. VIRGILIO E, Salvemini C, Treglia MG, Thai E, et al
    Hotspots of Anal Cancer Screening in a High-risk Population: A Clinical Study on Free Provision, Best Method, Self-sampling, and Independent Risk Factors.
    Anticancer Res. 2024;44:4465-4481.
    PubMed     Abstract available
    
    
    September 2024
57. HOSOKAWA A, Tamura H, Ichihara A, Imamura N, et al
    Pathological Complete Response to Liver Metastasis With Pembrolizumab in a Previously Treated Patient With Microsatellite Instability-high Colorectal Cancer.
    Anticancer Res. 2024;44:4119-4125.
    PubMed     Abstract available
    
    
    
58. SHIRAISHI T, Yamaguchi A, Shibasaki Y, Osone K, et al
    Risk Factors of Poor Outcomes After Colorectal Cancer Surgery for Patients With Severe Comorbidities.
    Anticancer Res. 2024;44:4073-4083.
    PubMed     Abstract available
    
    
    
59. COZZANI F, Ricchiuto M, Virgilio E, Viani L, et al
    The Controlling Nutritional Status (CONUT) Score Predicts Post-operatory Risks and Prognosis in Patients With Surgically Treated Colon Cancer: A Retrospective Study.
    Anticancer Res. 2024;44:3955-3964.
    PubMed     Abstract available
    
    
    
60. JINNO T, Yamaguchi J, Ogura A, Kokuryo T, et al
    Loss of Trefoil Factor 1 Accelerates the Immune Response to Colorectal Cancer.
    Anticancer Res. 2024;44:3757-3769.
    PubMed     Abstract available
    
    
    
61. FUKUSHIMA G, Sato E, Udo R, Tago T, et al
    Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in Human Colorectal Carcinoma.
    Anticancer Res. 2024;44:3899-3906.
    PubMed     Abstract available
    
    
    
62. KAYANO H, Mamuro N, Kamei Y, Ogimi T, et al
    Risk Factors Associated With Perioperative Skeletal Muscle Loss in Patients With Colorectal Cancer.
    Anticancer Res. 2024;44:4019-4029.
    PubMed     Abstract available
    
    
    
63. TAKEDA K, Kikuchi Y, Sawada YU, Kumamoto T, et al
    Simultaneously Detected Liver and Lung Metastases from Colorectal Carcinoma: A Potential Treatment Strategy.
    Anticancer Res. 2024;44:3945-3954.
    PubMed     Abstract available
    
    
    August 2024
64. KAMADA T, Furukawa K, Takahashi J, Aida T, et al
    Preoperative Vertebral Fracture: A Prognostic Factor in Stage I-III Colorectal Cancer.
    Anticancer Res. 2024;44:3533-3541.
    PubMed     Abstract available
    
    
    
65. YOKOTA Y, Nozawa H, Sonoda H, Yokoyama Y, et al
    Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition.
    Anticancer Res. 2024;44:3337-3342.
    PubMed     Abstract available
    
    
    
66. TSUJIO G, Fukuoka T, Sugimoto A, Yonemitsu K, et al
    The Efficacy of Chemical Bowel Preparation Against Incisional Surgical Site Infection in Colorectal Cancer Surgery: A Propensity Score Matching Study.
    Anticancer Res. 2024;44:3473-3480.
    PubMed     Abstract available
    
    
    
67. FUKUDA J, Sudo T, Kikuchi M, Kawahara A, et al
    Identification of DNA Repair-related Genes as Biomarkers Reflecting MSI, TMB, and TIL in Colorectal Cancer.
    Anticancer Res. 2024;44:3567-3575.
    PubMed     Abstract available
    
    
    
68. TAKAHASHI H, Kojima D, Wada H, Hanaoka K, et al
    A Bridge to Curative Surgery for Obstructive Colorectal Cancer: Self-expandable Metallic Stent Versus Decompression Tube.
    Anticancer Res. 2024;44:3427-3441.
    PubMed     Abstract available
    
    
    
69. MUKOHYAMA J, Koizumi M, Yamashita K, Yoshimi A, et al
    Knockdown of CDX2 Induces microRNA-221 Up-regulation in Human Colon Cancer Cells.
    Anticancer Res. 2024;44:3553-3556.
    PubMed     Abstract available
    
    
    July 2024
70. KOMORI K, Yoshida M, Tsukushi S, Kinoshita T, et al
    Combined Pubic Arch and Ischial Bone Resection for Metachronous and Frequent Local Recurrences of Rectal Cancer.
    Anticancer Res. 2024;44:3205-3211.
    PubMed     Abstract available
    
    
    
71. LEE SH, Kim SA, Park SJ, Lee MY, et al
    NUAK2 Inhibitors, KHKI-01128 and KHKI-01215, Exhibit Potent Anticancer Activity Against SW480 Colorectal Cancer Cells.
    Anticancer Res. 2024;44:2909-2919.
    PubMed     Abstract available
    
    
    
72. SHIOI I, Ogawa H, Naito R, Endo M, et al
    Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer.
    Anticancer Res. 2024;44:3013-3023.
    PubMed     Abstract available
    
    
    
73. TSUMURAYA H, Mimura K, Nakajima S, Hanayama H, et al
    Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in Patients With Colorectal Cancer.
    Anticancer Res. 2024;44:2933-2941.
    PubMed     Abstract available
    
    
    
74. KARLIKOVA M, Curillova M, Pecen L, Karnos V Jr, et al
    Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
    Anticancer Res. 2024;44:3105-3113.
    PubMed     Abstract available
    
    
    June 2024
75. MOON SU, Lee JH, Shah M, Yoon S, et al
    RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression.
    Anticancer Res. 2024;44:2471-2485.
    PubMed     Abstract available
    
    
    
76. TOREN W, Sasor A, Ansari D, Andersson R, et al
    ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical Resection.
    Anticancer Res. 2024;44:2597-2604.
    PubMed     Abstract available
    
    
    
77. MATSUDA A, Yamada T, Takahashi G, Matsumoto S, et al
    Significance of Adjuvant Chemotherapy for Obstructive Colorectal Cancer After Stent Placement: A Multicenter Retrospective Study.
    Anticancer Res. 2024;44:2737-2745.
    PubMed     Abstract available
    
    
    
78. LIM SC, Lee TB, Han SI
    Caffeic Acid Enhances Anticancer Drug-induced Apoptosis in Acid-adapted HCT116 Colon Cancer Cells.
    Anticancer Res. 2024;44:2587-2595.
    PubMed     Abstract available
    
    
    May 2024
79. WAGNER D, Karitnig R, Wienerroither V, Hau HM, et al
    Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for Colorectal Liver Metastases (CRLM).
    Anticancer Res. 2024;44:2177-2183.
    PubMed     Abstract available
    
    
    April 2024
80. WU CC, Su CC, Chen YH, Hsu CW, et al
    Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2024;44:1619-1628.
    PubMed     Abstract available
    
    
    
81. TANAKA H, Hayashi H, Tomita H, Tokumaru Y, et al
    Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal Cancer Outcome.
    Anticancer Res. 2024;44:1611-1618.
    PubMed     Abstract available
    
    
    
82. SHIRAISHI T, Tominaga T, Ono R, Noda K, et al
    Short- and Long-term Outcomes After Colonic Stent Insertion as a Bridge to Surgery in Elderly Colorectal Cancer Patients.
    Anticancer Res. 2024;44:1637-1643.
    PubMed     Abstract available
    
    
    
83. SYRJANEN K, Eskelinen M, Meklin J, Hendolin P, et al
    Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB).
    Anticancer Res. 2024;44:1513-1523.
    PubMed     Abstract available
    
    
    
84. BEPPU T, Yamamura K, Masuda T, Miyamoto H, et al
    High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
    Anticancer Res. 2024;44:1533-1539.
    PubMed     Abstract available
    
    
    
85. SATOYOSHI T, Hirohashi Y, Okuya K, Miyo M, et al
    CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer Survival.
    Anticancer Res. 2024;44:1603-1610.
    PubMed     Abstract available
    
    
    
86. AOYAMA T, Yukawa N, Saito A
    Clinical Impact of Nutrition and Inflammation Assessment Tools in Colorectal Cancer Treatment.
    Anticancer Res. 2024;44:1335-1351.
    PubMed     Abstract available
    
    
    March 2024
87. ZHENG W, Chen K, Lv Y, Lao W, et al
    Pyrvinium Pamoate Induces Cell Apoptosis and Autophagy in Colorectal Cancer.
    Anticancer Res. 2024;44:1193-1199.
    PubMed     Abstract available
    
    
    
88. EBATA Y, Nakanishi R, Tanaka Y, Kawazoe T, et al
    Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A Single Center Retrospective Cohort Study.
    Anticancer Res. 2024;44:1281-1287.
    PubMed     Abstract available
    
    
    
89. HARA S, Sakai D, Ikemura K, Shintani T, et al
    Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer.
    Anticancer Res. 2024;44:1219-1226.
    PubMed     Abstract available
    
    
    
90. SILVA EF, Fernandes BN, Marinello P, Deminice R, et al
    Pre and Post-high-intensity Interval Training Delays Colon Tumor Onset in a Syngeneic Mouse Model.
    Anticancer Res. 2024;44:1209-1217.
    PubMed     Abstract available
    
    
    
91. HEGEDUS D, Szemeredi N, Gabor M, Sas J, et al
    Cyclic Amines Coupled to Indole Derivatives With Improved Efflux Pump Inhibiting Activity in Bacteria and Cancer Cells.
    Anticancer Res. 2024;44:1149-1160.
    PubMed     Abstract available
    
    
    
92. ARDJMAND D, Kubota Y, Sato M, Han Q, et al
    Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells.
    Anticancer Res. 2024;44:929-933.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.